Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 224 of the 227 references it cites were found in a registry or an index; 42 of the 207 sources its claims cite were checked for support.

Recent Advances in Nanomicelles Delivery Systems.

Open access

Abstract

The efficient and selective delivery of therapeutic drugs to the target site remains the main obstacle in the development of new drugs and therapeutic interventions. Up until today, nanomicelles have shown their prospective as nanocarriers for drug delivery owing to their small size, good biocompatibility, and capacity to effectively entrap lipophilic drugs in their core. Nanomicelles are formed via self-assembly in aqueous media of amphiphilic molecules into well-organized supramolecular structures. Molecular weights and structure of the core and corona forming blocks are important properties that will determine the size of nanomicelles and their shape. Selective delivery is achieved via novel design of various stimuli-responsive nanomicelles that release drugs based on endogenous or exogenous stimulations such as pH, temperature, ultrasound, light, redox potential, and others. This review summarizes the emerging micellar nanocarriers developed with various designs, their outstanding properties, and underlying principles that grant targeted and continuous drug delivery. Finally, future perspectives, and challenges for nanomicelles are discussed based on the current achievements and remaining issues.

Overview

CoChat Summary

TL;DR

This paper is a review of nanomicelles as drug delivery systems, with emphasis on how polymer/surfactant design affects size, stability, biodistribution, and drug loading. It also surveys stimuli-responsive and targeted nanomicelles for anticancer delivery, highlighting pH, temperature, light, ultrasound, and redox-triggered release.

Key findings

  • Nanomicelles can improve delivery by entrapping drugs in a protective core-shell structure, increasing bioavailability and reducing side effects; the review notes lower dissociation kinetics than conventional surfactant micelles, about 1000-fold slower after dilution.
  • Surfactant micelles are reported in the 5–100 nm range, while polymeric nanomicelles are described as 1–200 nm; lower critical micellar concentration is emphasized as a stability advantage for DDSs.
  • The review reports several example systems with quantitative performance, including PEG-P(Asp-Hyd-ADR) releasing ADR more slowly as pH decreases from 7.4 to 3.0, PEG-PTMBPEC micelles swelling from 150 nm to ~400 nm in 3 h and to >1000 nm after 12 h at pH 4.0, and one dual-pH system that inhibited tumor development by 88%.
  • For anticancer delivery, the paper states that polymeric nanomicelles can increase drug water solubility by 10 to 5000 fold, and gives examples such as paclitaxel-loaded PCL-b-PEG-b-PCL micelles with loading up to 28%, doxorubicin-loaded micelles with 15–20% loading, and a temperature-sensitive system with 15% DOX release after 15 h at 30 °C versus 90% at 37 °C.

Methods

  • This is a narrative review of recent literature on nanomicelles delivery systems, organized by micelle type, polymer selection, preparation methods, biodistribution, targeting, and stimuli-responsive release.
  • The paper synthesizes findings from previously published studies and reports example data from those studies rather than presenting a new experimental sample of its own.
  • Its main analysis is qualitative comparison of design strategies and reported performance metrics across systems such as pH-sensitive, temperature-sensitive, light-sensitive, ultrasound-responsive, and redox-responsive nanomicelles.

Limitations

  • The paper itself states that only a few polymeric micelles have reached clinical-stage application, and that there are limitations to current materials, including poor encapsulation of some drugs, toxicity, and unfavorable immunological interactions such as antibody responses to PEG.
  • The review also notes that further studies are ongoing and that additional research is needed to develop safer materials with higher drug loading.
  • Evident from the text: because this is a review, the conclusions depend on heterogeneous prior studies with different systems and outcomes, and the paper does not provide a single unified experimental dataset.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nano11010070

Cites

224 of 224 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 6 Emerging drug delivery systems based on stimuli responsive polymeric nanomicelles (i) formation of micelles through pH and temperature external stimulus application; (ii) drug release; (iii) enhancing cell uptake of drugs and release under acidic effect; and (iv) strong redox potential is used to increase intracellular drug release inside cancer cells. Reprinted with permission from [135]. Copyright © 2013, Elsevier.
Figure 6 Emerging drug delivery systems based on stimuli responsive polymeric nanomicelles (i) formation of micelles through pH and temperature external stimulus application; (ii) drug release; (iii) enhancing cell uptake of drugs and release under acidic effect; and (iv) strong redox potential is used to increase intracellular drug release inside cancer cells. Reprinted with permission from [135]. Copyright © 2013, Elsevier.CC BY · PubMed Central
Figure 9 Structure of AAL-g-PMAA and self-assembly into nanomicelles and ibuprofen (IBU) can be loaded in the Core (up). Drug release profile, cytotoxicity study and bioimaging results (down). Reprinted with permission from [169]. Copyright © 2020, American Chemical Society.
Figure 9 Structure of AAL-g-PMAA and self-assembly into nanomicelles and ibuprofen (IBU) can be loaded in the Core (up). Drug release profile, cytotoxicity study and bioimaging results (down). Reprinted with permission from [169]. Copyright © 2020, American Chemical Society.CC BY · PubMed Central
Figure 13 (a) NIR-II and PA imaging of blood vessels using Affibody–DAPs, (b) NIR-II and PA imaging of SY1080 NPS, (c) The mechanism of bioerasable intermolecular donor–acceptor interaction of SPNP25 with ClO−, (d) IR thermal images of living mice with 4T1 tumors under 1064 nm laser excitation (1 W cm−2) at 48 h, (e) Diagram of the renal excretion of CDIR2 through the urinary system, (f,g) NIR-II images of monitoring the Pt(II) metallacycle-based NIR-II theranostic nanoprobe’s therapeutic response in HepG2 tumors. Reprinted with permission from [201]. Copyright © 2020, Elsevier.
Figure 13 (a) NIR-II and PA imaging of blood vessels using Affibody–DAPs, (b) NIR-II and PA imaging of SY1080 NPS, (c) The mechanism of bioerasable intermolecular donor–acceptor interaction of SPNP25 with ClO−, (d) IR thermal images of living mice with 4T1 tumors under 1064 nm laser excitation (1 W cm−2) at 48 h, (e) Diagram of the renal excretion of CDIR2 through the urinary system, (f,g) NIR-II images of monitoring the Pt(II) metallacycle-based NIR-II theranostic nanoprobe’s therapeutic response in HepG2 tumors. Reprinted with permission from [201]. Copyright © 2020, Elsevier.CC BY · PubMed Central
Figure 1 Schematic representation of unimer–micelle equilibrium in water. Reprinted with permission from [33]. Copyright © 2017, The Royal Society of Chemistry.
Figure 1 Schematic representation of unimer–micelle equilibrium in water. Reprinted with permission from [33]. Copyright © 2017, The Royal Society of Chemistry.CC BY · PubMed Central
Figure 2 Illustration of some different self-assembled micelles structure. Reprinted with permission from [41]. Copyright © 2017, The Royal Society of Chemistry.
Figure 2 Illustration of some different self-assembled micelles structure. Reprinted with permission from [41]. Copyright © 2017, The Royal Society of Chemistry.CC BY · PubMed Central
Figure 3 Structures of some commonly used polymers as micellar carrier: poly(ethylene glycol)-poly(ε-caprolactone) copolymers (PEG-PCL); poly(ethylene glycol)-b-poly(l-lactide) (PEG-PLA); Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) (PEG-PLGA); Poly(ethylene glycol)-block-poly(l-aspartic acid) (PEG-p(Asp); poly(ethylene glycol) poly(amino acid) (PEG-PAA);, d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Reprinted with permission from [52]. Copyright © 2018, American Chemical Society.
Figure 3 Structures of some commonly used polymers as micellar carrier: poly(ethylene glycol)-poly(ε-caprolactone) copolymers (PEG-PCL); poly(ethylene glycol)-b-poly(l-lactide) (PEG-PLA); Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) (PEG-PLGA); Poly(ethylene glycol)-block-poly(l-aspartic acid) (PEG-p(Asp); poly(ethylene glycol) poly(amino acid) (PEG-PAA);, d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Reprinted with permission from [52]. Copyright © 2018, American Chemical Society.CC BY · PubMed Central
Figure 4 Schematic illustration of the polymeric nanomicelles targeting for drug delivery Reprinted with permission from [105].Copyright © 2016, Elsevier.
Figure 4 Schematic illustration of the polymeric nanomicelles targeting for drug delivery Reprinted with permission from [105].Copyright © 2016, Elsevier.CC BY · PubMed Central
Figure 5 Schematic representation of carbon dots functionalized stearic-g-polyethyleneimine synthesis. Reprinted with permission from [127]. Copyright © 2021, Elsevier.
Figure 5 Schematic representation of carbon dots functionalized stearic-g-polyethyleneimine synthesis. Reprinted with permission from [127]. Copyright © 2021, Elsevier.CC BY · PubMed Central
Figure 7 (a) Chemical Structure of the prepared polymer (PEGS). (b) Preparation strategy of PEGS/HA/DOX delivery system. (c) DOX release mechanism in acidic tumor environment. Reprinted with permission from [161]. Copyright © 2020, American Chemical Society.
Figure 7 (a) Chemical Structure of the prepared polymer (PEGS). (b) Preparation strategy of PEGS/HA/DOX delivery system. (c) DOX release mechanism in acidic tumor environment. Reprinted with permission from [161]. Copyright © 2020, American Chemical Society.CC BY · PubMed Central
Figure 8 (A) Preparation of UCNP-Al-NH-PEG-NH-FA nanomicelles (B) Bioimaging results of KB cells treated with DOX-loaded UCNP-Al-NH-PEG-NH-FA for different time (1 h, 3 h, and 6 h) at 37 °C. Reprinted with permission from [17]. Copyright © 2018, Elsevier.
Figure 8 (A) Preparation of UCNP-Al-NH-PEG-NH-FA nanomicelles (B) Bioimaging results of KB cells treated with DOX-loaded UCNP-Al-NH-PEG-NH-FA for different time (1 h, 3 h, and 6 h) at 37 °C. Reprinted with permission from [17]. Copyright © 2018, Elsevier.CC BY · PubMed Central
Figure 10 Schematic illustration of the thermoresponsive hydrogel-micelles for DOX delivery and cancer treatment. Reprinted with permission from [177]. Copyright © 2021, Elsevier.
Figure 10 Schematic illustration of the thermoresponsive hydrogel-micelles for DOX delivery and cancer treatment. Reprinted with permission from [177]. Copyright © 2021, Elsevier.CC BY · PubMed Central
Figure 11 Synthesis process of polymeric micelles of CS-S-PLA-PNIPAM-co-PAAm and light triggered DOX release and imaging for cancer cells using copolymer micelles conjugated Au-NIR probe. Reprinted with permission from [187]. Copyright © 2020, Elsevier.
Figure 11 Synthesis process of polymeric micelles of CS-S-PLA-PNIPAM-co-PAAm and light triggered DOX release and imaging for cancer cells using copolymer micelles conjugated Au-NIR probe. Reprinted with permission from [187]. Copyright © 2020, Elsevier.CC BY · PubMed Central
Figure 12 (A) The design strategy of 3PEG–PCL micelles for DOX loading and release strategy. (B) (a) toxicity test of human oral squamous cell carcinoma (SAS) cells. (b) Bioimaging results of SAS cells treated with DOX and DOX-encapsulated micelles. (c) Cytotoxicity profiles calculated form real time analyzer. Reprinted with permission from [189]. Copyright © 2019, American Chemical Society.
Figure 12 (A) The design strategy of 3PEG–PCL micelles for DOX loading and release strategy. (B) (a) toxicity test of human oral squamous cell carcinoma (SAS) cells. (b) Bioimaging results of SAS cells treated with DOX and DOX-encapsulated micelles. (c) Cytotoxicity profiles calculated form real time analyzer. Reprinted with permission from [189]. Copyright © 2019, American Chemical Society.CC BY · PubMed Central
Figure 14 (A) Self-assembled of the prepared peptide-based ICG nanomicelles and (B) the NIR and ultrasound irradiation effects on the tumor mice. Reprinted with permission from [210]. Copyright © 2020, Elsevier.
Figure 14 (A) Self-assembled of the prepared peptide-based ICG nanomicelles and (B) the NIR and ultrasound irradiation effects on the tumor mice. Reprinted with permission from [210]. Copyright © 2020, Elsevier.CC BY · PubMed Central
Figure 15 Preparation of PTS-DP nanomicelles and their DOX loaded and release strategy under ROS trigger for enhanced chemo-photodynamic therapy. Reprinted with permission from [221]. Copyright © 2020, Elsevier.
Figure 15 Preparation of PTS-DP nanomicelles and their DOX loaded and release strategy under ROS trigger for enhanced chemo-photodynamic therapy. Reprinted with permission from [221]. Copyright © 2020, Elsevier.CC BY · PubMed Central
Figure 16 Preparation of phosphate micelle coated UCNPs and the UCNPs release mechanism under sPLA-2 enzyme trigger. Reprinted with permission from [21]. Copyright © 2017, Springer Nature.
Figure 16 Preparation of phosphate micelle coated UCNPs and the UCNPs release mechanism under sPLA-2 enzyme trigger. Reprinted with permission from [21]. Copyright © 2017, Springer Nature.CC BY · PubMed Central

Verification

Claims the paper makes

35 Valid · 19 Not valid · 137 Not checked · 30 Own results and interpretations

105 more claims · 18 with their cited sources checked

Create a free account to see all 221 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 88
  • Probably not a substantial claim. 34
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 227 references

Cited by

See all 156

Metadata

Authors
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I.
Affiliations
  • Changwon National University (KR)
  • Academy of Sciences Republic of Uzbekistan (UZ)
Corresponding author
Lee, Yong-Ill
Venue
Nanomaterials
Publisher
MDPI AG
Published
2020-12-30
Volume
11
Issue
1
Pages
70
ISSN
2079-4991 (ISSN-L)
OpenAlex
W3116967457
Cited by
156
References
227
Citations by year
2026: 21 · 2025: 40 · 2024: 41 · 2023: 19 · 2022: 25 · 2021: 9
FWCI
0.88
Type
journal article
Language
en
Open access
Locations
  • Nanomaterials (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Research Foundation of Korea (2020R1A2C2007028)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Surfactants and Colloidal Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
nanomicelles, drug delivery, nanocarriers, self-assembly, amphiphilic molecules, stimuli-responsive drug release, targeted drug delivery, pH-responsive, temperature-responsive, redox-responsive, light-responsive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent Advances in Nanomicelles Delivery Systems. https://app.cochat.ai/papers/10.3390/nano11010070
The paper
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020). Recent Advances in Nanomicelles Delivery Systems. Nanomaterials. https://doi.org/10.3390/nano11010070

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.